Laboratory of Chemical Biology and Genomics, Korea Research Institute of Bioscience and Biotechnology, University of Science and Technology, Yuseonggu, Daejon, Republic of Korea.
Int J Cancer. 2012 Aug 1;131(3):E190-203. doi: 10.1002/ijc.27381. Epub 2012 Jan 11.
Phosphatase of regenerating liver (PRL)-3, a member of a subgroup of protein tyrosine phosphatases that can stimulate the degradation of the extracellular matrix, is over-expressed in metastatic colorectal cancer (CRC) relative to primary tumors. To determine whether PRL-3-induced enhancement of migration and invasion is dependent on the expression of matrix metalloproteinases (MMPs), PRL-3 was expressed in DLD-1 human CRC cells. The motility, migration and invasion characteristics of the cells were examined, and metastasis to the lung was confirmed in a nude mouse using PRL-3-overexpressing DLD-1 cells [DLD-1 (PRL-3)]. Migration and invasion of the cells were inhibited by phosphatase and farnesyltransferase inhibitors. Expression of MMPs was enhanced 3- to 10-fold in comparison to control cells, and migration and invasion were partially inhibited by small interfering RNA (siRNA) knockdown of MMP-2, -13 or -14. Importantly, siRNA knockdown of MMP-7 completely inhibited the migration and invasion of DLD-1 (PRL-3) cells, whereas overexpression of MMP-7 increased migration. The expression of MMP-7 was also downregulated by phosphatase and farnesyltransferase inhibitors. It was found that PRL-3 induced MMP-7 through oncogenic pathways including PI3K/AKT and ERK and that there is a relationship between the expression of PRL-3 and MMP-7 in human tumor cell lines. The expression of MMP-13 and -14 was very sensitive to the inhibition of farnesyltransferase; however, the migration and invasion of DLD-1 (PRL-3) cells did not strongly depend on the expression of MMP-13 or -14. These results suggest that the migration and invasion of PRL-3-expressing CRC cells depends primarily on the expression of MMP-7.
肝再生磷酸酶-3(PRL-3)是蛋白酪氨酸磷酸酶亚组的成员,可刺激细胞外基质的降解,在转移性结直肠癌(CRC)中相对于原发性肿瘤过度表达。为了确定 PRL-3 诱导的迁移和侵袭增强是否依赖于基质金属蛋白酶(MMPs)的表达,在 DLD-1 人 CRC 细胞中表达了 PRL-3。检查了细胞的迁移、迁移和侵袭特性,并使用过表达 PRL-3 的 DLD-1 细胞[DLD-1(PRL-3)]在裸鼠中证实了肺转移。通过磷酸酶和法呢基转移酶抑制剂抑制细胞的迁移和侵袭。与对照细胞相比,MMPs 的表达增强了 3-10 倍,并且 MMP-2、-13 或 -14 的小干扰 RNA(siRNA)敲低部分抑制了迁移和侵袭。重要的是,MMP-7 的 siRNA 敲低完全抑制了 DLD-1(PRL-3)细胞的迁移和侵袭,而 MMP-7 的过表达则增加了迁移。MMP-7 的表达也被磷酸酶和法呢基转移酶抑制剂下调。发现 PRL-3 通过包括 PI3K/AKT 和 ERK 在内的致癌途径诱导 MMP-7,并且在人肿瘤细胞系中存在 PRL-3 和 MMP-7 之间的表达关系。MMP-13 和 -14 的表达对法尼基转移酶的抑制非常敏感;然而,DLD-1(PRL-3)细胞的迁移和侵袭并不强烈依赖于 MMP-13 或 -14 的表达。这些结果表明,表达 PRL-3 的 CRC 细胞的迁移和侵袭主要依赖于 MMP-7 的表达。
Zhonghua Zhong Liu Za Zhi. 2013-4
J Transl Med. 2023-9-9
Signal Transduct Target Ther. 2022-3-4
Int J Environ Res Public Health. 2020-2-1
Medchemcomm. 2017-2-16
Onco Targets Ther. 2017-1-10